ALLO icon

Allogene Therapeutics

155 hedge funds and large institutions have $460M invested in Allogene Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

10% less funds holding

Funds holding: 173155 (-18)

11% less call options, than puts

Call options by funds: $354K | Put options by funds: $399K

63% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 27

Holders
155
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$354K
Puts
$399K
Net Calls
Net Calls Change

Top Buyers

1 +$11.1M
2 +$7.26M
3 +$3.76M
4
BlackRock
BlackRock
New York
+$3.72M
5
Goldman Sachs
Goldman Sachs
New York
+$1.77M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$63.1K
102
$61.6K
103
$59K
104
$57K
105
$57K
106
$56K
107
$55.2K
108
$51.7K
109
$51.5K
110
$48.7K
111
$45.3K
112
$44.2K
113
$44K
114
$43.7K
115
$36.4K
116
$36.4K
117
$36K
118
$33.8K
119
$30.2K
120
$29.4K
121
$29.3K
122
$28.5K
123
$28K
124
$22K
125
$21.9K